Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4555221000168118 | Cabenuva Cabotegravir (cabotegravir 400 mg / 2 mL) modified release injection, 1 x 2 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4555231000168115 | Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Is a | cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | true | Inferred relationship | Some | ||
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | has TP | Cabenuva Cabotegravir | true | Inferred relationship | Some | ||
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | has TPUU | Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | true | Inferred relationship | Some | 235968883 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Is a | True | Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR